Moderna beats sales estimates as Covid shot gains market share
MODERNA reported fourth-quarter revenue that beat analysts’ expectations by gaining Covid vaccine market share on its rival, Pfizer.
UK-wide study reveals harm done by people not getting Covid-19 jabs
MORE than 7,000 people were hospitalised or died from Covid-19 in the UK during the summer of 2022 because they had not...
WHO sees 'incredibly low' Covid, flu vaccination rates as cases surge
LOW vaccination rates against the latest versions of Covid-19 and influenza are putting pressure on healthcare systems this winter, leading public health...
AstraZeneca buys respiratory vaccine developer Icosavax in US$1.1 billion deal
ASTRAZENECA said on Tuesday (Dec 12) it had agreed to buy respiratory syncytial virus (RSV) vaccine developer Icosavax in a deal valued...
Vaccine-maker Hilleman opens S$27m plant in Singapore to bolster pandemic preparedness
A LARGE-SCALE manufacturing facility that develops affordable vaccines in Singapore for common diseases and can easily switch to production of new vaccines...
Moderna expects lower 2023 Covid vaccine sales, shares tumble
MODERNA said on Thursday (Nov 2) its 2023 sales would only hit the low end of its previous forecast, reflecting weaker demand...
Pfizer’s foggy Covid outlook hits vaccine makers’ shares
PFIZER on Monday (Oct 16) set off a fresh round of concern about the size of the Covid-19 vaccine and treatment market...
Nobel medicine prize goes to mRNA Covid vaccine researchers
KATALIN Kariko and Drew Weissman won the Nobel medicine prize on Monday (Oct 2) for their work on messenger RNA (mRNA) technology...
Targeted Comirnaty Covid shot may arrive by end-October, vaccinations still key: MOH
PFIZER’S updated Comirnaty Covid-19 vaccine could arrive in Singapore by end-October, said Senior Minister of State for Health Janil Puthucheary in Parliament...
Moderna to scale down manufacturing of Covid vaccine
MODERNA on Wednesday (Sep 13) announced it was scaling down manufacturing of its Covid-19 vaccine, an updated version of which was approved...